# RILUZOLE
> **ANDA204430** · Abbreviated New Drug Application (Generic) · Sponsor: DAITO PHARMS CO LTD · Approved 2018-10-16
## Drug
- **FDA Application Number:** ANDA204430
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RILUZOLE
- **Generic name:** Riluzole
- **Active ingredients:** RILUZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** DAITO PHARMS CO LTD
- **First approval:** 2018-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204430)
---
*AI Analytics · CC0 1.0*